Italia Grenga

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Julius Strauss, Christopher R. Heery, Jeffrey Schlom et al. · Clinical Cancer Research · 2018 · 406 citations · Full text

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan et al. · The Lancet Oncology · 2017 · 292 citations · Full text

Medicine, Javelin Solid Tumor, Solid Tumours +6

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells

Caroline Jochéms, Massimo Fantini, Romaine I. Fernando et al. · Oncotarget · 2016 · 140 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +24

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury

Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst et al. · Cancer Immunology Research · 2015 · 136 citations · Full text

Immunology, Immunoediting, Pathology +16

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer

Christopher R. Heery, Nuhad K. Ibrahim, Philip M. Arlen et al. · JAMA Oncology · 2015 · 99 citations · Full text